Clinical Trial Update: Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not

View source ↗

Summary

A recruiting clinical trial evaluating outcomes for primary multiple myeloma patients who achieved minimal residual disease negativity after induction therapy, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Multiple Myeloma, Minimal Residual Disease | Status: RECRUITING